Dosage Regimen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New US patent likely to cover all vidofludimus calcium doses in MS

New US patent likely to cover all vidofludimus calcium doses in MS
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

United statesDaniel vittTrademark officeImmunic therapeuticDosage regimenChronic inflammatoryAutoimmune diseases

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium s Dosing Regimens in Multiple Sclerosis

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.

United statesEdna kaplanDaniel vittJessica breuPaula schwartzPrnewswire immunic incImmunic incRx communications groupTrademark officeExchange commissionFundamental new patent covers treatmentMultiple sclerosis intoVidofludimus calciumMultiple sclerosisUnless extended furtherProtecting specific dose strength

EQS-News: Immunic, Inc : Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium s Dosing Regimens in Multiple Sclerosis

EQS-News: Immunic, Inc : Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium s Dosing Regimens in Multiple Sclerosis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Rheinland pfalzUnited statesEdna kaplanJessica breuStates patentprotecting vidofludimusDaniel vittPaula schwartzImmunic incDistribution servicesExchange commissionRx communications groupTrademark officeReceives noticeDosing regimensMultiple sclerosisNew patent covers treatment